Angola vs Kazakhstan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Angola
54.0%
in 2025
Kazakhstan
49.0%
in 2025
Angola rank
151st
Kazakhstan rank
154th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Angola
- Kazakhstan
How they compare
Angola currently reports 54.0% against 49.0% in Kazakhstan, a difference of 5.0%.
That makes Angola's figure about 1.1 times Kazakhstan's.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Kazakhstan ahead.
Angola ranks 151st and Kazakhstan ranks 154th of 192 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Angola | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 35.9% | 51.4% | 15.5% | Kazakhstan |
| 2020s | 53.3% | 50.8% | 2.5% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Angola or Kazakhstan?
- Angola, at 54.0% against 49.0% in Kazakhstan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Angola and Kazakhstan?
- 5.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Kazakhstan?
- 18 years are reported by both, from 2008 to 2025.
- How do Angola and Kazakhstan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Angola ranks 151st and Kazakhstan ranks 154th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.